Adult education

GSK Leads Global Forum in Bangkok to Address Respiratory Health Challenges

GSK hosted the third annual RespiVerse Meeting on December 13 and 14 in Bangkok,Thailand. The event brought together renowned international speakers and healthcare professionals from 17 countries to a

12-18

MoonFox Analysis | Online Travel Platforms Empower Double 11 Shopping Festival, "Competing" to Drive Growth and New Trends

About us: Aurora Mobile (NASDAQ: JG) established in 2011,is a leading customer engagement and marketing technology service provider in China. Its business includes notification services,marketing grow

12-18

Great Bay Bio Completes First Close of Series B Financing

HONG KONG,Dec. 17,2024--Great Bay Bio (GBB) is thrilled to announce the successful first close of its Series B financing round. This milestone was achieved with the round led by a syndication of a wel

12-18

Globe Teleservices Signs International Voice Strategic Partnership with DITO Telecommunity

SINGAPORE,Dec. 17,2024--Globe Teleservices Pte. Ltd. (GTS),a leading global telecom solutions provider,has entered into an exclusive three-year agreement with DITO Telecommunity,the fastest-growing t

12-18

Over 100 Million Wi-Fi HaLow Devices To Arrive On The Market by 2029 as The Need for Scalable, Robust, Extended Range Wireless Connectivity Accelerates

ABI Research\'s latest whitepaper details how Wi-Fi HaLow\'s unique capabilities are already transforming IoT use cases

12-18

Lakeside Signs $1.5 Million Sales Agreement with Sinopharm Group Subsidiary

Agreement to Deliver Critical Medicines ITASCA,Ill.,Dec. 17,2024--Lakeside Holding Limited ("Lakeside" or the "Company") (Nasdaq: LSH),a U.S.-based cross-border supply chain soluti

12-18

Databricks is Raising $10B Series J Investment at $62B Valuation

Funding led by new investor Thrive Capital Company expects to cross $3B in revenue run rate and achieve positive free cash flow in fourth quarter

12-18

U.S. FDA approves Celltrion's STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab)

STEQEYMA (CT-P43) is approved for both adult and pediatric patients with plaque psoriasis (PsO) and active psoriatic arthritis (PsA) as well as adults with Crohn\'s disease (CD) and ulcerative coliti

12-18

DELTA ELECTRONICS POWERS SINGAPORE'S NATIONAL CORAL RESTORATION EFFORTS WITH ADVANCED AUTOMATION AND MONITORING TECHNOLOGY

SINGAPORE,Dec. 10,2024-- Delta,a global leader in power management and IoT-based smart green solutions,has joined the National Parks Board of Singapore\'s (NParks) 100k Corals Initiative to support co

12-11

District neighboring Hong Kong attracts global investment for commerce, trade, and cultural tourism

SHENZHEN,China,Dec. 10,2024-- Luohu district of Shenzhen,an economic powerhouse in South China,signed a total investment of 62.1 billion yuan (US$8.5 billion) at the 2024 Shenzhen Global Investment Pr

12-11

Home Previous 71 72 73 74 75 76 77 Next Tail

10 Items Per Page (Page 74 / 105) Total 1044 Items

Newest

1Cangxi County Holds 2026 New Year's Cultural Performance for the Public

Cangxi County Holds 2026 New Year's Cultural Performance for the Public

2The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

6Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

©copyright 2009-2020 Singapore Info Map